{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:22:30Z","timestamp":1761945750046,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":5703,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/labinvest.3700539","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T06:04:53Z","timestamp":1173074693000},"page":"591-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2"],"prefix":"10.1016","volume":"87","author":[{"given":"Shinji","family":"Hattori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipok K","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumasa","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Tonomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinao","family":"Onoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamanoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"Nagasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.3700539_bib1","first-page":"135","article-title":"Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved","volume":"38","author":"Guyot","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1038\/labinvest.3700539_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/labinvest.3700030","article-title":"Portal tract fibrogenesis in the liver","volume":"84","author":"Ramadori","year":"2004","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.3700539_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.LAB.0000054178.01162.E4","article-title":"The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis","volume":"83","author":"Kinnman","year":"2003","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.3700539_bib4","first-page":"265","article-title":"Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat","volume":"74","author":"Tuchweber","year":"1996","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.3700539_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1053\/jhep.2001.28457","article-title":"Transforming growth factor beta and the liver","volume":"34","author":"Bissell","year":"2001","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700539_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0016-5085(98)70539-6","article-title":"Expression of activin A is increased in cirrhotic and fibrotic rat livers","volume":"114","author":"Sugiyama","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.3700539_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0016-5085(00)70370-2","article-title":"An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis","volume":"118","author":"Cho","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.3700539_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/labinvest.3780384","article-title":"Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury","volume":"81","author":"Kinnman","year":"2001","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.3700539_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/002215540004800610","article-title":"Expression of epidermal growth factor and its receptor in cirrhotic liver disease","volume":"48","author":"Komuves","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"10.1038\/labinvest.3700539_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cyto.2004.11.001","article-title":"Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice","volume":"29","author":"Sudo","year":"2005","journal-title":"Cytokine"},{"key":"10.1038\/labinvest.3700539_bib11","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.20425","article-title":"Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats","volume":"40","author":"Parsons","year":"2004","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700539_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700539_bib13","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1074\/jbc.M409381200","article-title":"SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells","volume":"280","author":"Tsukada","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700539_bib14","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/sj.onc.1207755","article-title":"Oncogenic potential of the RUNX gene family: \u2018overview'","volume":"23","author":"Ito","year":"2004","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.3700539_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"10.1038\/labinvest.3700539_bib16","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1074\/jbc.275.6.4453","article-title":"MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1","volume":"275","author":"Xiao","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700539_bib17","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1681\/ASN.V1181534","article-title":"A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar\u2013Kyoto rats","volume":"11","author":"Wada","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.3700539_bib18","doi-asserted-by":"crossref","first-page":"L103","DOI":"10.1152\/ajplung.00187.2001","article-title":"A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis","volume":"283","author":"Matsuoka","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1038\/labinvest.3700539_bib19","first-page":"701","article-title":"Selective suppression of initial cytokine response facilitates liver regeneration after extensive hepatectomy in rats","volume":"51","author":"Tsutsumi","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.1038\/labinvest.3700539_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00011-005-1381-6","article-title":"Effect and mechanisms of FR167653, a dual inhibitor of TNF-alpha and IL-1, on BCG plus LPS induced-liver injury","volume":"54","author":"Yao","year":"2005","journal-title":"Inflamm Res"},{"key":"10.1038\/labinvest.3700539_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.510250327","article-title":"Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients","volume":"25","author":"Selberg","year":"1997","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700539_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s005350050264","article-title":"Pathobiology of hepatic stellate cells","volume":"34","author":"Burt","year":"1999","journal-title":"J Gastroenterol"},{"key":"10.1038\/labinvest.3700539_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0168-8278(00)80398-0","article-title":"Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture","volume":"32","author":"Reeves","year":"2000","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.3700539_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700539_bib25","doi-asserted-by":"crossref","first-page":"G1051","DOI":"10.1152\/ajpgi.00128.2002","article-title":"DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells","volume":"283","author":"Cao","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.3700539_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-5793(02)03276-3","article-title":"p38 MAPK mediates the regulation of alpha1(I) procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of rat hepatic stellate cells(1)","volume":"528","author":"Varela-Rey","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1038\/labinvest.3700539_bib27","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1126\/science.270.5244.2008","article-title":"Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction","volume":"270","author":"Yamaguchi","year":"1995","journal-title":"Science"},{"key":"10.1038\/labinvest.3700539_bib28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/jhep.2001.28790","article-title":"TAK1\/JNK and p38 have opposite effects on rat hepatic stellate cells","volume":"34","author":"Schnabl","year":"2001","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700539_bib29","doi-asserted-by":"crossref","first-page":"27161","DOI":"10.1074\/jbc.274.38.27161","article-title":"Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression","volume":"274","author":"Hanafusa","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700539_bib30","doi-asserted-by":"crossref","first-page":"24530","DOI":"10.1074\/jbc.M311804200","article-title":"Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2","volume":"279","author":"Bertrand-Philippe","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700539_bib31","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1038\/sj.onc.1205937","article-title":"Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein","volume":"21","author":"Lee","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.3700539_bib32","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.3700539_bib33","doi-asserted-by":"crossref","first-page":"17360","DOI":"10.1074\/jbc.M207631200","article-title":"Expression of galectin-3 in skeletal tissues is controlled by Runx2","volume":"278","author":"Stock","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700539_bib34","doi-asserted-by":"crossref","first-page":"39470","DOI":"10.1074\/jbc.M306345200","article-title":"p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation","volume":"278","author":"Dean","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700539_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/labinvest.3780452","article-title":"Pathogenic roles of tumor necrosis factor receptor p55-mediated signals in dimethylnitrosamine-induced murine liver fibrosis","volume":"82","author":"Kitamura","year":"2002","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.3700539_bib36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells","volume":"119","author":"Marra","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.3700539_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbrc.2004.01.038","article-title":"Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet","volume":"315","author":"Kawaguchi","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3700539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700539","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722016932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722016932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:41:49Z","timestamp":1758397309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722016932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0023683722016932"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.3700539","relation":{},"ISSN":["0023-6837"],"issn-type":[{"type":"print","value":"0023-6837"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700558","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}